MSLN and ovarian carcinoma: Moreover, Lanitis and colleagues developed human ovarian cancer xenograft mouse models by subcutaneous inoculation of the A1847 cell line into NSG mice and reported that intratumoral administration of mesothelin-redirected CAR-Ts culminated in tumor outgrowth suppression while the animals were under soluble mesothelin treatment (136).